http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35559849

Outgoing Links

Predicate Object
contentType Multicenter Study|Journal Article
endingPage 8413
issn 1432-1335
0171-5216
issueIdentifier 11
pageRange 8403-8413
publicationName Journal of Cancer Research and Clinical Oncology
startingPage 8403
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8a164947bf22a0f503cb7cc15f295ac8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d81da77204896288426ec58241f626c8
bibliographicCitation Ye S, Bai L, Qi Y, Jin Y, Yang Y, Song F, Gong P, Zhang T. Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study. J Cancer Res Clin Oncol. 2023 Sep;149(11):8403–13. doi: 10.1007/s00432-023-04768-1. PMID: 37084112.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5428-928X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39b705558296c56f5ed341fa3f691fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_311b17805bb3f0a1deaf223f61418362
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aa1d3aca11373e7ca601f2e44a8867c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_765c95f509f3f88fb787b237e8973320
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68a9283e9224e39453e25583353b72f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1261d4aad9cd47ec8c00e6f82ad0c62
date 2023-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00432-023-04768-1
https://pubmed.ncbi.nlm.nih.gov/37084112
isPartOf https://portal.issn.org/resource/ISSN/1432-1335
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4574
https://portal.issn.org/resource/ISSN/0171-5216
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352

Total number of triples: 34.